Mohamed M. Shamseldin

Halwan, C, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Caspase-11 Mediated Hyperinflammation Impairs CD8+ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection.

Caspase-11 Mediated Hyperinflammation Impairs CD8+ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV.

Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV.

Journal: Science advances

Published: September 26, 2025

Discovery of CD4+ T cell-recognized B. pertussis antigens that reduce airway colonization.

Discovery of CD4+ T cell-recognized B. pertussis antigens that reduce airway colonization.

Journal: JCI insight

Published: August 20, 2025

Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission.

Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 06, 2025

A BcfA-containing intranasal vaccine generated TH17 immunity and reduced B. bronchiseptica colonization and disease in mice.

A BcfA-containing intranasal vaccine generated TH17 immunity and reduced B. bronchiseptica colonization and disease in mice.

Journal: NPJ vaccines

Published: June 19, 2025

AI-based decoding of long covid cognitive impairments in mice using automated behavioral system and comparative transcriptomic analysis.

AI-based decoding of long covid cognitive impairments in mice using automated behavioral system and comparative transcriptomic analysis.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2025

The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming.

The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming.

Journal: Frontiers in immunology

Published: May 27, 2024

Opposing effects of acellular and whole cell pertussis vaccines on Bordetella pertussis biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues.

Opposing effects of acellular and whole cell pertussis vaccines on Bordetella pertussis biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues.

Journal: bioRxiv : the preprint server for biology

Published: February 08, 2024

Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer's disease.

Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer's disease.

Journal: Brain, behavior, and immunity

Published: December 08, 2023

A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.

A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 05, 2023

Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective.

Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective.

Journal: Nature communications

Published: April 19, 2023

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization.

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization.

Journal: Frontiers in immunology

Published: March 08, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026